New Leaf Ventures Inc
New Leaf Ventures Inc. engages in processing, packaging, marketing, and distributing cannabis and related products. The company offers its products under the DAMA and Goodies brand names. It also provides consulting, real property and equipment leasing, intellectual property licensing, and management services. New Leaf Ventures Inc. was incorporated in 2018 and is headquartered in Vancouver, Cana… Read more
New Leaf Ventures Inc (NLVVF) - Net Assets
Latest net assets as of September 2023: $-1.74 Million USD
Based on the latest financial reports, New Leaf Ventures Inc (NLVVF) has net assets worth $-1.74 Million USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($5.75 Million) and total liabilities ($7.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-1.74 Million |
| % of Total Assets | -30.32% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
New Leaf Ventures Inc - Net Assets Trend (2018–2022)
This chart illustrates how New Leaf Ventures Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for New Leaf Ventures Inc (2018–2022)
The table below shows the annual net assets of New Leaf Ventures Inc from 2018 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-1.35 Million | -203.63% |
| 2021-12-31 | $1.31 Million | +397.48% |
| 2020-12-31 | $-439.30K | -10.72% |
| 2019-12-31 | $-396.76K | -994.55% |
| 2018-12-31 | $-36.25K | -- |
Equity Component Analysis
This analysis shows how different components contribute to New Leaf Ventures Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1525187700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $13.01 Million | % |
| Other Comprehensive Income | $106.25K | % |
| Other Components | $822.43K | % |
| Total Equity | $-1.35 Million | 100.00% |
New Leaf Ventures Inc Competitors by Market Cap
The table below lists competitors of New Leaf Ventures Inc ranked by their market capitalization.
Equity Growth Attribution
This analysis shows how different factors contributed to changes in New Leaf Ventures Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 1,306,816 to -1,354,292, a change of -2,661,108 (-203.6%).
- Net loss of 3,518,382 reduced equity.
- New share issuances of 664,869 increased equity.
- Other comprehensive income decreased equity by 25,513.
- Other factors increased equity by 217,918.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.52 Million | -259.79% |
| Share Issuances | $664.87K | +49.09% |
| Other Comprehensive Income | $-25.51K | -1.88% |
| Other Changes | $217.92K | +16.09% |
| Total Change | $- | -203.63% |
Book Value vs Market Value Analysis
This analysis compares New Leaf Ventures Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-0.01 | $0.00 | x |
| 2019-12-31 | $-0.07 | $0.00 | x |
| 2020-12-31 | $-0.06 | $0.00 | x |
| 2021-12-31 | $0.13 | $0.00 | x |
| 2022-12-31 | $-0.11 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently New Leaf Ventures Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -177.67%
- • Asset Turnover: 0.86x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-60.64%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-58.52K |
| 2019 | 0.00% | -226.13% | 2.71x | 0.00x | $-1.13 Million |
| 2020 | 0.00% | -321.80% | 0.32x | 0.00x | $-6.56 Million |
| 2021 | -303.20% | -160.29% | 0.42x | 4.56x | $-4.09 Million |
| 2022 | 0.00% | -177.67% | 0.86x | 0.00x | $-3.38 Million |
Industry Comparison
This section compares New Leaf Ventures Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| New Leaf Ventures Inc (NLVVF) | $-1.74 Million | 0.00% | N/A | $2.98K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |